NeoBiocon partners with Novartis to offer Vildagliptin for Diabetics in UAE
We are delighted to extend our partnership with Novartis and Biocon for these novel products. Biocon’s leadership in the diabetes segment will augur well for marketing these brands in UAE, Dr. B. R. Shetty said.